BOSTON, Sept. 6 /PRNewswire/ -- Surface Logix Inc. announced today the
appointment of W. James O'Shea to the Company's Board of Directors.
Currently Mr. O'Shea is President and Chief Operating Officer at Sepracor
Inc. in Marlborough, MA. As a member of the Board, Mr. O'Shea will provide
strategic advice on the commercialization and partnering activities of the
Company's pipeline of new drugs.
"I am extremely pleased to welcome Jim to the Surface Logix Board,"
said Jim Mahoney, President and CEO of Surface Logix. "The breadth of his
commercial development experience in the pharmaceutical industry is exactly
what our company needs as we continue to progress our assets through
clinical development and consider our partnering options."
Prior to joining Sepracor in October 1999, Mr. O'Shea was Senior Vice
President of Sales and Marketing and Medical Affairs for Zeneca
Pharmaceuticals, a business unit of Zeneca Inc. While at Zeneca, he also
held several management positions of increasing responsibility in
international sales and marketing in the U.S. and U.K. Mr. O'Shea is an
executive Board member and past Chairman of the National Pharmaceutical
Council and is also a Board member of CollaGenex.
Mr. O'Shea is a graduate of Liverpool Lord Byron University. He
received an Honors Degree in Applied Physics from the Institute of Physics.
About Surface Logix Inc.
Surface Logix Inc. uses its expertise in biophysical chemistry to
create new small molecule drugs that are optimized to meet the challenges
of human physiology. The company is advancing multiple internal programs
focused primarily on cardiovascular, metabolic, inflammatory and fibrotic
diseases. For more information, please visit http://www.surfacelogix.com.
Contact:
David H. Donabedian, Ph.D.
Vice President, Business Development
617.746.8520
Media:
Kari Watson
MacDougall Biomedical Communications Inc.
508.647.0209
SOURCE Surface Logix Inc.
 back to top
Related links:
http://www.surfacelogix.com
CONTACT:
David H. Donabedian, Ph.D. Vice President,
Business Development of Surface Logix Inc., +1-617-746-8520; or
Media: Kari Watson of MacDougall Biomedical Communications Inc.
for Surface Logix Inc., +1-508-647-0209
|
